@article{5c758032844348d99fd1015debedeebf,
title = "Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes",
abstract = "To evaluate the dose-response relationship of the recombinant glucagon-like peptide-1 (7-36) amide (rGLP-1) administered by continuous subcutaneous infusion (CSCI) in subjects with type 2 diabetes, with respect to reductions in fasting, postprandial and 11-h serum glucose profiles.",
keywords = "Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Double-Blind Method, Female, Glucagon-Like Peptide 1, Humans, Hypoglycemic Agents, Infusions, Subcutaneous, Male, Middle Aged, Peptide Fragments, Placebos, Postprandial Period",
author = "Torekov, {Signe S{\o}rensen} and Kipnes, {M S} and Harley, {R E} and Holst, {J J} and Ehlers, {M R}",
note = "{\textcopyright} 2011 Blackwell Publishing Ltd.",
year = "2011",
doi = "10.1111/j.1463-1326.2011.01388.x",
language = "English",
volume = "13",
pages = "639--43",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "7",
}